摘要
目的使用全自动酶联免疫吸附试验(ELISA)系统检测抗线粒体M2抗体并探讨其临床意义。方法收集267例血清样本,包括112例原发性胆汁性肝硬化患者(PBC)、77例乙型肝炎病毒(HBV)感染者和78名健康对照者血清样本,使用全自动ELISA系统检测抗线粒体M2抗体,评估该系统检测抗线粒体M2抗体的精密度和抗线粒体M2抗体的临床价值。结果全自动ELISA系统的精密度较好,批内和天间的变异系数(CV)均〈5%。PBC患者抗线粒体M2抗体的阳性率为89.3%(100/112),抗体浓度值以大于800 RU/m L为主(63%,71/112)。HBV感染者抗线粒体M2抗体的阳性率为5.2%(4/77),3例抗体浓度值在25~100 RU/mL之间,1例在100 RU/mL以上;健康对照组中抗线粒体M2抗体阳性率为5.1%(4/78),4例抗体阳性者抗体浓度值均在25~50 RU/mL之间。结论抗线粒体M2抗体ELISA检测的系统化保证了检验结果的稳定性,可为PBC的诊断和与其他肝病的鉴别诊断提供更有价值的实验室依据。
Objective To detect anti-mitochondrial M2 antibody by automatic enzyme-linked immunosorbent assay( ELISA) system and to investigate its clinical significance. Methods A total of 267 serum samples[( 112 samples from patients with primary biliary cirrhosis( PBC),77 samples from patients infected with hepatitis B virus( HBV) and 78 samples from healthy controls] were detected for anti-mitochondrial M2 antibody by automatic ELISA system. The precision and the clinical significance of detecting anti-mitochondrial M2 antibody were evaluated. Results The precision was good. The within-run and inter-day coefficients of variation( CV) were 〈 5%. The patients with PBC had positive rate 89. 3%( 100 /112) for anti-mitochondrial M2 antibody,usually in high levels( 〉 800 RU / m L,63%,71 /112). The positive rate of anti-mitochondrial M2 antibody was 5. 2%( 4 /77) in patients with HBV infection,including 3cases of 25-100 RU / m L and 1 case of 〉 100 RU / m L,and it was 5. 1%( 4 /78) in healthy subjects. Conclusions Automatic ELISA system for the detection of anti-mitochondrial M2 antibody guarantees the stability of results. It will provide valuable laboratory reference for the diagnosis of PBC and the differential diagnosis for other liver diseases.
出处
《检验医学》
CAS
2015年第12期1234-1237,共4页
Laboratory Medicine
基金
卫生计生委医药卫生科技发展研究中心资助项目(28-5-5)